Introduction: The integration of behavioral health services in primary care settings presents an opportunity to enhance the delivery of tobacco cessation interventions in the primary care setting, but guidance on evidence-based treatments for tobacco use disorder that fits the brief format of integrated primary care (IPC) is limited. This meta-analysis summarizes the outcomes of brief behavioral interventions targeting tobacco use that can be delivered in IPC settings. Methods: A literature search was conducted to locate empirical studies examining tobacco cessation interventions that could be implemented in an IPC setting. A random effects meta-analytic approach was utilized with odds ratios as the effect size. Subgroup analyses were conducted to determine the extent to which a number of study, participant, and intervention characteristics affected treatment outcome. Results: A total of 36 studies were included (n = 12 975 patients). Patients in the intervention groups exhibited significantly greater odds of smoking cessation compared with those in the comparison groups (OR = 1.78, p < .001). Subgroup analyses did not reveal significant sources of heterogeneity attributable to moderators such as methodological quality, gender, bioverification, follow-up time period, or intervention characteristics (such as setting, type, or length of intervention). Conclusions: Brief tobacco cessation interventions that can be delivered in IPC settings were found to be effective. Future research in this area might evaluate ways to improve the dissemination and implementation of these types of interventions in IPC settings. Implications: The integration of behavioral health services into primary care presents a unique opportunity to increase the delivery of tobacco cessation interventions, as behavioral health providers in these settings are experts in behavior change interventions and may have more time to deliver these interventions than primary care providers. Results from the current meta-analysis demonstrate that brief tobacco cessation interventions that can be implemented in the IPC setting are effective. Future research in this area might examine ways to improve the dissemination and implementation of brief interventions for tobacco use in IPC settings.
Introduction
The U.S. Department of Health and Human Services Clinical Practice Guideline recommends treatment for tobacco use disorders in the primary care (PC) setting. 1 The movement to improve mental and behavioral health services in PC through integration 2 may be a way to increase the implementation of tobacco use interventions in PC.
Because the majority (ie, ~80%) of smokers in the United States visit a PC provider, 1 PC providers are uniquely positioned to intervene with a large number of smokers. Although PC-based tobacco cessation interventions have traditionally been intended for delivery by the PC provider, providers have difficulty in consistently implementing these interventions because of the self-reported lack of knowledge regarding how to deliver nonpharmacological interventions for tobacco cessation, lack of time in appointments to do so, and feeling discouraged by previous experience with patients who failed to quit. 3, 4 Behavioral health providers (BHPs) (eg, social workers and psychologists) working in the PC setting are available to complement and extend behavioral health services offered by PC providers. In the context of tobacco cessation, these providers may have more time to assist the patient with their goals (eg, determine his or her specific cessation needs, motivation, and tailored intervention strategies) and will likely have more general training in behavior change interventions.
Common forms of integrating mental and behavioral health services in PC include (1) primary care-behavioral health, in which mental health professionals are staffed in PC and function as members of the patients' PC team, 5 and (2) care management, which focuses on care managers (ie, nurses and mental health professionals) using evidence-based strategies and measurement-based care to deliver high quality care for common presenting concerns in PC. 6 In both platforms, BHPs bring the ability to deliver nonpharmacological interventions for tobacco use disorders to the PC team. BHPs have the potential to fill a crucial gap in the delivery of interventions for tobacco use disorder, given their background and experience with behavior change interventions, 7 and because they are physically well-positioned to work with other PC team members who can prescribe tobacco cessation medications.
A course of treatment with a BHP can be understood in the context of the stepped care model. 8 Patients who do not respond to a very brief treatment conducted by their PC provider (eg, the 5As; ask, advise, assess, assist, arrange 1 ) may be referred to the BHP for more intensive treatment. In turn, patients who do not respond to an intervention by the BHP may be referred to more intensive services (eg, longer term, more intensive therapy) if they are still having difficulty achieving their goals. An episode of treatment with a BHP allows for a more intensive intervention than minimal treatment (eg, the 5As), but ideally occurs in six or fewer appointments. The length and modalities (eg, individual, group, and telephone) of those appointments can vary based on the PC clinic. 9 As such, it is necessary for BHPs to be familiar with brief evidence-based interventions for tobacco use disorders that can be conducted within the context of integrated PC (IPC). In addition, specific evidence-based guidance regarding the most effective characteristics of the behavioral intervention would help guide clinical practice. In the absence of such data, BHPs are left to using strategies such as adapting longer interventions to fit this model of care and modifying existing interventions to fit the pace and nature of IPC.
Previous studies have found tobacco cessation interventions delivered by health care professionals (including physicians, nurses, and dentists) to improve quit rates, [10] [11] [12] [13] [14] [15] and behavioral interventions in conjunction with medication increase the chance of quit success above and beyond the use of medication alone. 16 Several meta-analyses have found support for motivational interviewing [17] [18] [19] as a specific type of treament for tobacco use. Individual, group, internet, and telephonebased counseling all have evidence as effective methods of delivering tobacco cessation treatment. [20] [21] [22] [23] [24] A major limitation when attempting to apply this large body of literature to work conducted by BHPs is that none of these previous reviews has specifically examined the state of the evidence regarding tobacco cessation interventions that fit the contingencies of clinical care in an IPC setting. Therefore, the aim of the current study is to determine the strength of the evidence for tobacco use treatments that could fit in the context and format of IPC, as well as to describe the factors that may moderate the relationship between these brief treatments and treatment outcome.
Methods
Information Sources/Search/Study Selection A literature search was conducted in PubMed from January 1990 to March 2016 using the terms "tobacco" or "smok*" and the specifier "human" in combination with each of the following: brief, short, abbreviated, treatment, intervention, counseling, family medicine, general practice, or PC, but "not" children, youth, juvenile, pediatric, or adolescent (as our focus was on adult patients). In addition, reference lists of meta-analyses on the topic of tobacco cessation were examined to locate potentially eligible studies. Abstracts that described behavioral interventions for tobacco use were reviewed. The full text of articles that were potentially eligible was reviewed (by Master's-level doctoral students and by the first author) to determine whether each study met eligibility criteria (see Figure 1 ).
Eligibility Criteria
Inclusion and exclusion criteria were written with the goal of identifying tobacco cessation interventions that could be implemented in the PC setting by BHPs. Eligible studies recruited current adult (≥18 years) tobacco users and tested at least one nonpharmacological treatment of six or fewer appointments (geared towards tobacco cessation) against at least one comparison condition. Eligible studies reported tobacco cessation outcome data, used random assignment, were written in English and were published in a peer-reviewed journal. Studies were excluded if they included child or adolescent samples or vulnerable populations, if the delivery of the intervention required special training or equipment, if the focus of the intervention was training providers, if there was no face-to-face contact between the interventionist and the patient, if only one group received medication, or if the intervention was conducted in settings (inpatient, home visits) or using strategies (eg, contingency management) that would not generalize to PC.
Data Analysis
All data analyses were conducted using Comprehensive MetaAnalysis software Version 3.0. Two raters independently extracted data from each article. Consistent with several past meta-analyses in the tobacco literature, 20, 23, 25 the most stringent analyses from each study were used. This was defined as using the longest follow-up time point from each study, choosing bioverified abstinence over self-report when available, choosing continuous abstinence over point prevalence abstinence, and choosing intent-to-treat analyses over complete case analyses. Discrepancies in selection of analyses were identified by the first author, and reviewers resolved discrepancies via discussion. Rates of inter-rater reliability were calculated.
Participant characteristics were extracted when available and included gender, age, baseline cigarettes per day, baseline Fagerström Test for Nicotine Dependence score, and type of tobacco used. Intervention characteristics were also extracted from each study, including the type of intervention delivered (categories included 5As/5Rs, cognitive-behavioral therapy, motivational intervention [motivational interviewing or stage-based intervention], health education, and simple advice), the type of provider who delivered the intervention, intervention format (group vs. individual), the number of intervention appointments, and the total time of intervention. Study characteristics that were extracted from articles included publication year, whether or not bioverification (eg, cotinine, nicotine, or carbon monoxide levels) was used to assess abstinence, the time at which treatment outcome was assessed (dichotomized into <6 month follow-up vs. ≥6 month follow-up), whether the study was closer to an efficacy (ie, under tightly controlled experimental conditions) or effectiveness (ie, under "real-world" conditions) trial, and the setting from which participants were recruited (dichotomized into PC vs. non-PC setting).
Coders also rated study quality using the 12-item Methodological Quality Scale, 26 a measure used in a number of previous reviews and meta-analyses in the tobacco literature 22, 25 to evaluate study quality. The primary outcome of interest was tobacco cessation. When available, odds ratios were taken directly from each publication. Otherwise, odds ratios were generated in comprehensive metaanalysis using either reported statistics (eg, p-values, chi-squared) or raw data (eg, frequency of abstinence in intervention vs. comparison group). We used a random (vs. fixed) effects approach, which assumes a distribution of effect sizes attributable to the influence of moderating variables. 27 Subgroup analyses were conducted to determine the extent to which a number of study, participant, and intervention characteristics influenced treatment outcome. Only categories that included four or more effect sizes were included, 28 in order to provide a sufficient number of effect sizes within each respective category and thus reduce excess leverage of outlying effect sizes. Cochran's Q statistic was generated to test for heterogeneity attributable to each moderator. Q statistic serves as a means by which to compare levels of observed heterogeneity based on sampling error (ie, within-and between-study dispersion) with expected levels of heterogeneity based on true differences across conditions (ie, "true" dispersion). A significant Q statistic indicates that moderator variables may be contributing to variability in effect sizes. 29 Four techniques were used to determine the extent to which publication bias affected the results of the overall sample: (1) metaregression analyses with year of publication regressed on effect size to determine whether earlier published studies found greater effect sizes relative to more recent studies, which may indicate the presence of publication bias 30 ; (2) the classic fail-safe N approach 31 which calculates the number of null findings required to render a significant effect as nonsignificant; (3) Egger's linear regression method 32 to identify the presence of imprecise (ie, large standard error) effect sizes; and (4) Duval and Tweedie's trim-and-fill method, 33 in which the studies are "trimmed" from the right of the funnel plot and imputed on the left side to resolve funnel plot asymmetry. If asymmetry exists, then the overall effect and 95% confidence interval are recalculated. The overlap of the adjusted 95% confidence interval with an odds ratio of one indicates the presence of publication bias.
Results

Publication Bias
Year of publication was not significantly negatively correlated with odds ratios (B = 0.00, Q = 0.07, p = .80, ns), suggesting lack of evidence for publication bias on this indicator. The classic fail-safe N approach to publication bias was significant (Z = 8.83), showing that a total of 829 null findings would be required to render the overall analyses nonsignificant (ie, p < .05). The Egger's linear regression approach was significant (t = 3.36, p < .001), indicating the presence of imprecise effect sizes to the right of the overall summary odds ratio and the potential presence of publication bias. Finally, results from Duval and Tweedie's trim-and-fill method did not suggest the presence of publication bias. Although several studies were trimmed and imputed, this did not result in significant adjustments to the overall odds ratio (adjusted OR = 1.37; 95% CI: 1.07, 1.73). Given the results obtained from Egger's linear regression approach, the influence of publication bias cannot be ruled out definitively.
Participant Characteristics
A total of 36 articles were eligible for inclusion, resulting in 12 975 patients included in the main analyses in this study. The average age of participants was 42.76 years (SD = 9.44, median = 41.4, range = 21.8-58.5; based on 27 studies reporting age) and the sample was 52.7% male (median = 54%, range = 0%-100%; based on 33 studies reporting gender). At baseline, participants smoked an average of 17.88 cigarettes per day (SD = 6.28, median = 18.4, range = 6.3-27.4; based on 24 studies reporting cigarettes per day). A total of 12 studies reported nicotine dependence scale scores, with 7 using the Fagerström Test for Nicotine Dependence score. The average Fagerström Test for Nicotine Dependence score was 4.23 (SD = 1.40, median = 4.4, range = 2.5-6.2), indicating low to moderate dependence. Only one study included participants who used both cigarette and noncigarette tobacco products, and the remainder focused exclusively on cigarette smoking.
Study Characteristics
Just over half of the studies (53%) used some form of bioverification to confirm abstinence (see Table 1 for study and intervention characteristics). Most studies (83%) measured outcome at a follow-up time period of six months or longer. Over half (58%) studied the effiacy of a nonpharmacological intervention, while the remainder (42%) studied the effectiveness of an intervention. Finally, just over a third (37%) of studies recruited participants directly from a PC setting.
Intervention Characteristics
Interventions averaged 2.64 appointments in length (SD = 1.96, range = 1-6, modal number of appointments = 1) and total length of intervention averaged 113.67 minutes (SD 161.55, range = 1.40-540.00 minutes). Approximately two-thirds (67.6%) of the interventions were delivered by health professionals (eg, physicians, nurses, and dentists). Most studies (n = 31, 86%) examined one-on-one (individual) interventions for tobacco use, three studies examined both group and individual interventions, and two studies looked at only group interventions. The types of interventions tested included the following: motivational interventions (n =13), cognitive-behavioral therapy (n = 10), health education (n = 7), simple advice (n = 5), the 5As/5Rs (n = 4), relapse prevention (n = 2), multicomponent interventions (n = 1), and referral (n = 1).
Methodological Quality
The inter-rater reliability of methodological quality ratings was excellent (κ = 0.90). The methodological quality of the studies included in this meta-analysis was medium to high (M = 11.17, SD = 2.22) and consistent with meta-analyses using a similar scale in the substance use literature. 22, 70, 71 Methodological quality rating was not associated with likelihood of tobacco cessation (B = −0.01, Q = 0.02, p = .88, ns).
Overall Treatment Effects
The inter-rater reliability of data extracted from the 36 studies included in this review was excellent (κ = 0.93). As shown in Figure 2 , across all studies included in the meta-analysis, patients in the intervention group exhibited significantly greater odds of smoking cessation compared with those in the comparison group (OR = 1.78, p < .001, 95% CI [1.44, 2.21]).
Participant Characteristics
Gender was not found to be a significant moderator of smoking cessation outcomes (B = 0.00, Q = 0.07, p = .79, ns). An inverse relationship approaching statistical significance was found between baseline cigarettes per day and odds of tobacco cessation (ie, as the number of baseline cigarettes per day increased, likelihood of abstinence decreased; B = −0.04; Q = 3.83; p = .05).
Study Characteristics
The outcomes of studies using bioverification to confirm tobacco cessation (OR = 
Intervention Characteristics
The type of intervention delivered (ie, motivational intervention, CBT, health education, 5As/5Rs, and simple advice) was not associated with likelihood of tobacco cessation, as evidenced by the omnibus comparison of active interventions (Q = 3.63, p = .46, ns). A follow-up comparison of studies employing the two most commonly tested interventions (CBT vs. motivational interventions) also did not suggest significant differences in odds of tobacco cessation (Q = 1.32, p = .25, ns).
Neither the length of the active intervention (B = −0.00, Q = 1.35, p = .25, ns) nor the total number of active intervention appointments (B = −0.05, Q = 0.73, p = .39, ns) was found to moderate smoking cessation outcomes.
Discussion
This is the first meta-analysis to synthesize the literature on randomized clinical trials of tobacco cessation treatment that specifically focused on interventions that could feasibly be delivered by BHPs within IPC settings. Across the studies identified, tobacco cessation interventions had strong support, with the overall effect size (OR = 1.78) matching other meta-analytic studies of nonpharmacological tobacco interventions. 10, 11, 14, 15, [17] [18] [19] [20] [21] [22] [23] [24] This finding supports the use of tobacco treatments consistent with the IPC model and points to the utility of using behavioral treatments delivered by BHPs to complement traditional PC-based (ie, pharmacological) interventions. Furthermore, patients recruited from PC and non-PC settings did not have different cessation outcomes, suggesting that tobacco cessation interventions can be delivered effectively from the PC setting.
A cardinal characteristic of IPC is the use of the minumum number of necessary appointments to provide an intervention effectively. The eligibilty criteria for this meta-analysis were set using the maximum number of appointments typically observed within IPC settings (ie, ≤6 appointments). However, in the IPC literature, the modal number of IPC appointments is often found to be one, 72 and the average appointment length is 30 minutes. 73 In the trials reviewed in this study, neither the length of the active nor the total number of active intervention appointments was found to moderate smoking cessation outcomes. Thus, it would seem that using BHPs to deliver behavioral tobacco cessation treatments in PC settings can be both brief and evidence-based, making the intervention economical and feasible for most PC clinics. BHPs have variable training backgrounds and different theoretical practice orientations. Our findings suggest that the type of intervention (eg, motivational interviewing, cognitive-behavioral) is not related to the outcome of tobacco cessation interventions. Therefore, it would appear that BHPs could have the latitude to choose a tobacco cessation intervention approach that matches their clinical training or background, which reduces the need for extensive additional training in tobacco cessation strategies. However, the number of studies in each treatment category was small, warranting caution regarding interpretation of these findings.
Future Directions
Given the strong evidence for brief tobacco interventions consistent with IPCs' clinical practice, we suggest that the dissemination and implementation of these interventions is a necessary next step, especially considering that tobacco cessation is not often identified within the literature as a common presenting problem that BHPs routinely address. 74 Efforts have focused on training medical providers to provide behavioral tobacco cessation interventions. 75 However, BHPs typically have mental health training backgrounds, making behavioral tobacco interventions a natural fit for their skill set. Additional work examining the facilitators and barriers to implementing tobacco interventions would help us to refine future implementation strategies in BHPs. Current work within general mental health settings may help provide examples of ways to help BHPs implement tobacco interventions. 76 Another area for future research is PC-based treatments for noncigarette tobacco products. Only one study eligible for the current metaanalysis recruited participants who used tobacco products other than cigarettes. 52 As such, we cannot draw firm conclusions about treatment efficacy for noncigarette tobacco products. A recent meta-analysis on smokeless tobacco users found variability in the success of behavioral interventions for smokeless tobacco use across 17 trials, 77 suggesting that use of these products may require different intervention strategies from what healthcare providers have been utilizing. Given that up to 7% of male patients in the United States use smokeless tobacco products, 78 further research to guide possible BHP-delivered behavioral treatments for this unique subgroup of tobacco users is warranted.
The current meta-analysis focused exclusively on tobacco cessation as an outcome in order to compare the overall effect size with other meta-analyses in the literature and because this was the most widely reported outcome in the eligible studies. However, outcomes other than cessation may be important to assess when determining the effects of brief interventions for tobacco use in this setting. For example, given that improvement in functioning is often a stated goal of IPC services, BHPs could work with patients who use tobacco to increase their self-efficacy related to making a quit attempt, could enhance motivation to enroll in more intensive tobacco cessation treatment or use pharmacotherapy as an adjunct to treatment, could work with patients to help them move along in stage of change, and could work with patients to reduce their tobacco use. Additionally, as part of an integrated team, BHPs participate in the continuous provision of services provided by the PC team, meaning that their participation in tobacco cessation efforts with any given patient may be organized over long periods of time that include intervals with no efforts at tobacco cessation. 79 In this context, future research on the ability of BHPs to advance meaningful change in tobacco-related outcomes other than cessation is warranted, as is an examination of less traditional but more PC-consistent intervention schedules.
Another area for future research is examining additional considerations for the increasing emphasis on team-based care and how that may influence tobacco interventions. IPC provides a team with a range of providers capable of helping patients with multiple components of tobacco use (ie, pharmacological and behavioral aspects). Additional work examining the specific mechanisms of how the team can optimize care delivery in busy PC environments would be an important contribution to the literature. Research designed to understand patient and provider preferences, clinic flow characteristics, and the role that each team member plays would improve the team-based delivery of tobacco cessation interventions within PC. Finally, group medical visits (shared medical appointments) led by an array of PC team members (eg, nursing staff, behavioral health providers, pharmacisits, and PCPs) could capitalize on the strengths of various professionals and may be a cost-effective option for delivering tobacco cessation services in PC.
Limitations
Although this meta-analysis has a number of strengths, it is not without limitations. The small number of available effect sizes in certain groups precluded the possibility of conducting subgroup analyses (eg, with all of the different types of treatments studied, studying group vs. individual interventions, studying long-term effects of these interventions). Furthermore, small numbers of available effect sizes in other subgroups (eg, only 7 out of 41 effect sizes were reported for follow-ups <6 months) mean that findings from these analyses should be considered tentative until additional studies are conducted in these domains.
The possibility for publication bias and the "file-draw problem" is a risk inherent in conducting any meta-analysis. The examination of publication bias via four separate indices suggests that we cannot definitely rule out the influence of publication bias. Similarly, in meta-analyses, heterogeneity can present statistical and interpretive concerns. Because we utilized the random-effects approach and investigated several putative sources of heterogeneity, we are confident that the conclusions drawn in this study are accurate and are a fair representation of the literature.
Conclusions
The current meta-analysis adds to the vast literature already supporting the use of behavioral interventions to aid tobacco cessation efforts by providing evidence for the use of brief interventions fitting the format and focus of IPC settings. This is significant because of an increased emphasis of integrating behavioral health services into PC settings and the high percentage of patients who use tobacco who access PC and the lack of access to or engagement in evidence-based tobacco cessation interventions outside of PC. Important next steps include the dissemination and implementation of brief tobacco cessation interventions, specifically targeting behavioral health providers in IPC settings and examining how integrated teams can best work together to address tobacco use, which continues to be a significant worldwide public health concern. 
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